FRA:NOV - Deutsche Boerse Ag - DK0062498333 - Common Stock - Currency: EUR
Overall NOV gets a fundamental rating of 7 out of 10. We evaluated NOV against 52 industry peers in the Pharmaceuticals industry. NOV has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NOV is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, NOV could be worth investigating further for growth and quality investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 21.39% | ||
ROE | 75.51% | ||
ROIC | 44.39% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 46.51% | ||
PM (TTM) | 34.51% | ||
GM | 84.33% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.7 | ||
Debt/FCF | 1.6 | ||
Altman-Z | 5.27 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.74 | ||
Quick Ratio | 0.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.76 | ||
Fwd PE | 13.28 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 26.35 | ||
EV/EBITDA | 12.99 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.6% |
FRA:NOV (7/7/2025, 7:00:00 PM)
59.09
-1.75 (-2.88%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 2.6% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.76 | ||
Fwd PE | 13.28 | ||
P/S | 6.46 | ||
P/FCF | 26.35 | ||
P/OCF | 14.93 | ||
P/B | 14.14 | ||
P/tB | 67.18 | ||
EV/EBITDA | 12.99 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 21.39% | ||
ROE | 75.51% | ||
ROCE | 55.72% | ||
ROIC | 44.39% | ||
ROICexc | 53.11% | ||
ROICexgc | 110% | ||
OM | 46.51% | ||
PM (TTM) | 34.51% | ||
GM | 84.33% | ||
FCFM | 24.53% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.7 | ||
Debt/FCF | 1.6 | ||
Debt/EBITDA | 0.6 | ||
Cap/Depr | 284.1% | ||
Cap/Sales | 18.77% | ||
Interest Coverage | 108.03 | ||
Cash Conversion | 81.52% | ||
Profit Quality | 71.08% | ||
Current Ratio | 0.74 | ||
Quick Ratio | 0.56 | ||
Altman-Z | 5.27 |